Sign up to save your podcasts
Or
Share Episode 3: Facioscapulohumeral muscular dystrophy, Duchenne, and the Sarepta-FDA shakeup
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 3: Facioscapulohumeral muscular dystrophy, Duchenne, and the Sarepta-FDA shakeup
In our neuromuscular episode, Sam and Ali interview Kristin Zwickau about the challenges facing pediatric patients with facioscapulohumeral muscular dystrophy and other rare diseases when it comes to drug development. Ali discusses the historical contributions of Charles Bell, William Gowers, and Guillaume Duchenne. Sam closes with a rundown on recent news surrounding Sarepta Therapeutics and the FDA.
View all episodes
By Ali Christy and Sam MackenzieIn our neuromuscular episode, Sam and Ali interview Kristin Zwickau about the challenges facing pediatric patients with facioscapulohumeral muscular dystrophy and other rare diseases when it comes to drug development. Ali discusses the historical contributions of Charles Bell, William Gowers, and Guillaume Duchenne. Sam closes with a rundown on recent news surrounding Sarepta Therapeutics and the FDA.